美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

REIN THERAPEUTICS INC

1.32

+0.02001.54%

盤後：1.330.0100+0.76%19:39 EDT

成交量：6.15萬

成交額：8.06萬

市值：3,171.50萬

市盈率：-0.50

高：1.35

開：1.30

低：1.24

收：1.30

52周最高：4.40

52周最低：1.04

股本：2,402.65萬

流通股本：2,002.77萬

量比：0.34

換手率：0.31%

股息：- -

股息率：- -

每股收益(TTM):-2.6428

每股收益(LYR):-3.5054

淨資產收益率：-79.38%

總資產收益率：-18.24%

市淨率：10.54

市盈率(LYR):-0.38

資料載入中...

總覽公司新聞公告

Rein Therapeutics獲得歐洲監管部門批准，啓動Lti-03治療特發性肺纖維化的二期臨牀試驗

REIN THERAPEUTICS INC - FDA建議公司提交完整回應函處理修訂研究報告及相關説明 - SEC文件

REIN THERAPEUTICS INC向SEC提交招股説明書，涉及銷售股東出售最多1000萬股普通股

Rein Therapeutics向SEC提交招股説明書擬出售多達1000萬股普通股

Rein Therapeutics Inc 預計每股虧損 25 美分 - 財報前瞻

Rein Therapeutics Inc 預計每股虧損 22 美分 - 財報前瞻

總規模470億港幣，晶泰科技創AI藥物發現合作訂單新紀錄

美國 FDA擱置肺病試驗後，Rein Therapeutics 暫停給藥

Rein Therapeutics Inc 預計每股虧損 24 美分 - 財報前瞻

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RNTX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNTX\",,,,,undefined,":{"symbol":"RNTX","market":"US","secType":"STK","nameCN":"REIN THERAPEUTICS INC","latestPrice":1.32,"timestamp":1760385600000,"preClose":1.3,"halted":0,"volume":61522,"hourTrading":{"tag":"盘后","latestPrice":1.33,"preClose":1.32,"latestTime":"19:39 EDT","volume":521,"amount":699.66,"timestamp":1760398788788},"delay":0,"floatShares":20027700,"shares":24026500,"eps":-2.642829,"marketStatus":"未開盤","change":0.02,"latestTime":"10-13 16:00:00 EDT","open":1.3,"high":1.345,"low":1.24,"amount":80562.8313686,"amplitude":0.080769,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.642829,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1760428800000},"marketStatusCode":0,"adr":0,"listingDate":1498708800000,"exchange":"NASDAQ","adjPreClose":1.3,"preHourTrading":{"tag":"盘前","latestPrice":1.25,"preClose":1.29,"latestTime":"08:18 EDT","volume":1597,"amount":2040.1500927,"timestamp":1760357908090},"postHourTrading":{"tag":"盘后","latestPrice":1.33,"preClose":1.32,"latestTime":"19:39 EDT","volume":521,"amount":699.66,"timestamp":1760398788788},"volumeRatio":0.339347},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNTX\",,,,,undefined,":{"symbol":"RNTX","floatShares":20027700,"roa":"-18.24%","roe":"-79.38%","lyrEps":-3.505399,"volumeRatio":0.339347,"shares":24026500,"dividePrice":0,"high":1.345,"amplitude":0.080769,"preClose":1.3,"low":1.24,"week52Low":1.04,"pbRate":"10.54","week52High":4.4,"institutionHeld":0,"latestPrice":1.32,"eps":-2.642829,"divideRate":0,"volume":61522,"delay":0,"ttmEps":-2.642829,"open":1.3,"prevYearClose":2.3,"prevWeekClose":1.3,"prevMonthClose":1.145,"prevQuarterClose":1.145,"fiveDayClose":1.19,"twentyDayClose":1.11,"sixtyDayClose":1.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-14","symbol":"RNTX","fiscalQuarterEnding":"2025/06","expectedEps":-0.22,"name":null,"time":"盤後","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2025-05-15","symbol":"RNTX","fiscalQuarterEnding":"2025/03","expectedEps":-0.21,"name":null,"time":"盤後","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.25},{"market":"US","date":"2025-04-07","symbol":"RNTX","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1743998400000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2024-11-14","symbol":"RNTX","fiscalQuarterEnding":"2024/09","expectedEps":-0.25,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2024-08-14","symbol":"RNTX","fiscalQuarterEnding":"2024/06","expectedEps":-0.25,"name":null,"time":"盤後","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1758772800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNTX","date":"2025-10-10","current":-0.499465,"percent":0.639785,"low":-2.000549,"twenty":-1.459659,"median":-0.615534,"eighty":-0.469167,"high":-0.401342,"avg":-0.858088,"sd":0.471706,"marketCap":31927997},"quantilePoints":[{"date":"2025-01-17","current":-1.459659,"twenty":-1.48337,"median":-1.467068,"eighty":-1.447804,"marketCap":42681903},{"date":"2025-01-24","current":-1.630077,"twenty":-1.576729,"median":-1.478183,"eighty":-1.446322,"marketCap":47665070},{"date":"2025-01-31","current":-1.467069,"twenty":-1.741219,"median":-1.496707,"eighty":-1.462623,"marketCap":42898563},{"date":"2025-02-07","current":-1.704171,"twenty":-1.704171,"median":-1.526344,"eighty":-1.459659,"marketCap":49831664},{"date":"2025-02-14","current":-1.741218,"twenty":-1.704171,"median":-1.578211,"eighty":-1.462623,"marketCap":50914961},{"date":"2025-02-21","current":-1.98573,"twenty":-1.794566,"median":-1.630077,"eighty":-1.468551,"marketCap":58064721},{"date":"2025-02-28","current":-1.533754,"twenty":-1.79753,"median":-1.630077,"eighty":-1.47596,"marketCap":44848497},{"date":"2025-03-07","current":-1.467069,"twenty":-1.753073,"median":-1.607848,"eighty":-1.468551,"marketCap":42898563},{"date":"2025-03-14","current":-1.496707,"twenty":-1.741218,"median":-1.552277,"eighty":-1.467069,"marketCap":43765200},{"date":"2025-03-21","current":-1.430022,"twenty":-1.733809,"median":-1.518935,"eighty":-1.461141,"marketCap":41815266},{"date":"2025-03-28","current":-1.311471,"twenty":-1.704171,"median":-1.507821,"eighty":-1.431504,"marketCap":38348715},{"date":"2025-04-04","current":-1.259605,"twenty":-1.704171,"median":-1.496707,"eighty":-1.416685,"marketCap":36832099},{"date":"2025-04-11","current":-0.545587,"twenty":-1.696762,"median":-1.481888,"eighty":-1.32629,"marketCap":34308123},{"date":"2025-04-17","current":-0.577063,"twenty":-1.667124,"median":-1.474478,"eighty":-1.296652,"marketCap":36287438},{"date":"2025-04-25","current":-0.640015,"twenty":-1.630077,"median":-1.467069,"eighty":-1.259605,"marketCap":40246068},{"date":"2025-05-02","current":-0.573565,"twenty":-1.630077,"median":-1.459659,"eighty":-0.64701,"marketCap":36067514},{"date":"2025-05-09","current":-0.601544,"twenty":-1.630077,"median":-1.437431,"eighty":-0.622528,"marketCap":37826905},{"date":"2025-05-16","current":-0.825375,"twenty":-1.622667,"median":-1.430022,"eighty":-0.622528,"marketCap":51902033},{"date":"2025-05-23","current":-0.696336,"twenty":-1.607848,"median":-1.415203,"eighty":-0.629523,"marketCap":42665230},{"date":"2025-05-30","current":-0.696336,"twenty":-1.584138,"median":-1.407793,"eighty":-0.629523,"marketCap":42665230},{"date":"2025-06-06","current":-0.705061,"twenty":-1.560428,"median":-1.311471,"eighty":-0.635119,"marketCap":43199785},{"date":"2025-06-13","current":-0.712292,"twenty":-1.550055,"median":-1.296652,"eighty":-0.639316,"marketCap":43642859},{"date":"2025-06-20","current":-0.592974,"twenty":-1.539682,"median":-1.259605,"eighty":-0.638616,"marketCap":36332127},{"date":"2025-06-27","current":-0.524276,"twenty":-1.524863,"median":-1.24849,"eighty":-0.622528,"marketCap":32122917},{"date":"2025-07-03","current":-0.54597,"twenty":-1.518935,"median":-0.809312,"eighty":-0.609134,"marketCap":33452141},{"date":"2025-07-11","current":-0.535123,"twenty":-1.515971,"median":-0.771713,"eighty":-0.598047,"marketCap":32787529},{"date":"2025-07-18","current":-0.506198,"twenty":-1.508562,"median":-0.726755,"eighty":-0.578462,"marketCap":31015230},{"date":"2025-07-25","current":-0.513429,"twenty":-1.504116,"median":-0.717873,"eighty":-0.562281,"marketCap":31458305},{"date":"2025-08-01","current":-0.421229,"twenty":-1.501152,"median":-0.708677,"eighty":-0.556817,"marketCap":25809102},{"date":"2025-08-08","current":-0.417509,"twenty":-1.496707,"median":-0.703515,"eighty":-0.543648,"marketCap":25581194},{"date":"2025-08-15","current":-0.434435,"twenty":-1.490779,"median":-0.698131,"eighty":-0.532953,"marketCap":26618269},{"date":"2025-08-22","current":-0.445213,"twenty":-1.481888,"median":-0.696336,"eighty":-0.524276,"marketCap":26334772},{"date":"2025-08-29","current":-0.445213,"twenty":-1.478924,"median":-0.689114,"eighty":-0.516321,"marketCap":26334772},{"date":"2025-09-05","current":-0.537801,"twenty":-1.474478,"median":-0.673872,"eighty":-0.514875,"marketCap":31811472},{"date":"2025-09-12","current":-0.425513,"twenty":-1.472996,"median":-0.650825,"eighty":-0.513429,"marketCap":25169516},{"date":"2025-09-19","current":-0.453092,"twenty":-1.467069,"median":-0.643512,"eighty":-0.506198,"marketCap":26800874},{"date":"2025-09-26","current":-0.470822,"twenty":-1.467069,"median":-0.629523,"eighty":-0.496939,"marketCap":27849604},{"date":"2025-10-03","current":-0.457032,"twenty":-1.465587,"median":-0.622528,"eighty":-0.470507,"marketCap":27033925},{"date":"2025-10-10","current":-0.539771,"twenty":-1.459659,"median":-0.615534,"eighty":-0.469167,"marketCap":31927997}],"updateTime":1760423550920},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNTX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1122656434","title":"Rein Therapeutics獲得歐洲監管部門批准，啓動Lti-03治療特發性肺纖維化的二期臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1122656434","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122656434?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 19:42","pubTimestamp":1760010157,"startTime":"0","endTime":"0","summary":"Rein Therapeutics获得欧洲监管部门批准，启动Lti-03治疗特发性肺纤维化的二期临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"1141656991","title":"REIN THERAPEUTICS INC - FDA建議公司提交完整回應函處理修訂研究報告及相關説明 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1141656991","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141656991?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 20:06","pubTimestamp":1758542777,"startTime":"0","endTime":"0","summary":"据向SEC提交的文件显示，FDA建议REIN THERAPEUTICS INC提交完整回应函，以处理修订后的研究报告和相关证明材料。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"1160830076","title":"REIN THERAPEUTICS INC向SEC提交招股説明書，涉及銷售股東出售最多1000萬股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1160830076","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160830076?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 06:13","pubTimestamp":1756937629,"startTime":"0","endTime":"0","summary":"REIN THERAPEUTICS INC向SEC提交招股说明书，涉及销售股东出售最多1000万股普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"1177289991","title":"Rein Therapeutics向SEC提交招股説明書 擬出售多達1000萬股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1177289991","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177289991?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 05:05","pubTimestamp":1756933546,"startTime":"0","endTime":"0","summary":"Rein Therapeutics向美国证券交易委员会(SEC)提交了招股说明书，该文件涉及股东拟出售多达1000万股普通股的要约和销售事宜。\n根据SEC文件显示，此次股票出售将由现有股东进行，涉及的股票数量高达1000万股普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX","BK4139"],"gpt_icon":0},{"id":"2559946180","title":"Rein Therapeutics Inc  預計每股虧損 25 美分 - 財報前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2559946180","media":"路透中文","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559946180?lang=zh_tw&edition=fundamental","pubTime":"2025-08-16 04:37","pubTimestamp":1755290226,"startTime":"0","endTime":"0","summary":"Rein Therapeutics Inc  预计每股亏损 25 美分 - 财报前瞻) Rein Therapeutics Inc RNTX.OQ RNTX.O将于8月18日公布截至2025年9月30日的财报(，预计季度收入不会有变化。LSEG分析师对Rein Therapeutics Inc的平均预期是每股亏损25美分。华尔街对 Rein Therapeutics Inc 的 12 个月目标价中位数为 7.00 美元，比上次收盘价 1.16 美元高出约 83.5%。8月15日 - 本摘要于北京时间 8 月 15 日 20:37 由机器生成。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nL4T3U716H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX"],"gpt_icon":0},{"id":"2558570982","title":"Rein Therapeutics Inc  預計每股虧損 22 美分 - 財報前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2558570982","media":"路透中文","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558570982?lang=zh_tw&edition=fundamental","pubTime":"2025-08-09 07:05","pubTimestamp":1754694309,"startTime":"0","endTime":"0","summary":"Rein Therapeutics Inc  预计每股亏损 22 美分 - 财报前瞻) Rein Therapeutics Inc RNTX.OQ RNTX.O将于8月12日公布截至2025年6月30日的财报(，预计季度营收不会有变化。LSEG的分析师平均预计Rein Therapeutics Inc每股亏损22美分。华尔街对 Rein Therapeutics Inc 的 12 个月目标价中位数为 7.00 美元，比上次收盘价 1.11 美元高出约 84.1%。8月8日 - 本摘要于北京时间 8 月 8 日 23:05 由机器生成。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL4S3U02MO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX"],"gpt_icon":0},{"id":"2557317799","title":"總規模470億港幣，晶泰科技創AI藥物發現合作訂單新紀錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2557317799","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557317799?lang=zh_tw&edition=fundamental","pubTime":"2025-08-06 00:53","pubTimestamp":1754412780,"startTime":"0","endTime":"0","summary":"根据协议条款，晶泰科技与 DoveTree 就多款处于临床前阶段的大分子及小分子创新药资产达成合作，并将针对一系列 DoveTree 指定的靶点进行新药研发，DoveTree 独家享有相关药物全球范围的独家开发和商业化权利。此次合作创下人工智能+机器人新药研发领域订单规模的新纪录。这使得晶泰科技成为极其难得的战略合作伙伴，并将有机会深刻变革药物发现的合作模式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4744811_ZH44811_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4080","ADC","BK4139","BK1141","BK1617","ENTA","02228","RNTX","BK4231"],"gpt_icon":0},{"id":"2543547552","title":"美國 FDA擱置肺病試驗後，Rein Therapeutics 暫停給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2543547552","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543547552?lang=zh_tw&edition=fundamental","pubTime":"2025-06-13 04:34","pubTimestamp":1749760486,"startTime":"0","endTime":"0","summary":"美国 FDA搁置肺病试验后，Rein Therapeutics 暂停给药路透6月12日 - Rein Therapeutics RNTX.O周四表示，在美国食品和药物管理局对其肺病药物的一项中期临床试验进行搁置后，该公司已暂停了在美国的入组和患者给药。 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nL4T3SF1EM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX"],"gpt_icon":0},{"id":"2534646676","title":"Rein Therapeutics Inc  預計每股虧損 24 美分 - 財報前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2534646676","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534646676?lang=zh_tw&edition=fundamental","pubTime":"2025-05-10 05:46","pubTimestamp":1746827167,"startTime":"0","endTime":"0","summary":"Rein Therapeutics Inc  预计每股亏损 24 美分 - 财报前瞻Rein Therapeutics Inc RNTX.OQ RNTX.O将于5月13日公布截至3月31日的业绩。LSEG分析师对Rein Therapeutics Inc的平均预期是每股亏损24美分。华尔街对 Rein Therapeutics Inc 的 12 个月目标价中位数为 10.00 美元，高于其最新收盘价 1.72 美元。5月9日 - 本摘要于北京时间 5 月 9 日 21:46 机器生成。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL4T3RH26Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}]}}